US EditionHHS chief RFK Jr. says he’s ordered a ‘complete review’ of chemical abortion pill
- Health and Human Services Secretary Robert F. Kennedy Jr. Ordered a complete FDA review of the abortion pill mifepristone during a Senate hearing on May 15, 2025.
- Kennedy has called for a thorough review after a recent study from a conservative think tank revealed that complication rates associated with mifepristone abortions are considerably higher than those reported on the FDA-approved labeling.
- The report analyzed 865,727 abortions from 2017-2023 and found 10.93% experienced serious complications such as sepsis, hemorrhaging, and emergency room visits, compared to under 0.5% in clinical trials.
- Kennedy emphasized the need for at least a modification to the pill’s labeling and assigned FDA Director Marty Makary to oversee a thorough review, while Makary acknowledged that the FDA might take further steps if new evidence indicates increased risks.
- The review could lead to reinstating stricter prescribing safeguards, though reproductive rights groups disagree and warn the review may harm access to a medication used by millions for 25 years.
24 Articles
24 Articles
RFK Jr. Announces 'Complete Review' of Abortion Pill After 'Alarming' New Study Reveals Dangers
The Food and Drug Administration will perform a ‘complete review’ of the abortion medication mifepristone, Health and Human Services Secretary Robert F. Kennedy Jr. announced Thursday in a Senate health, Education, Labor and Pensions Committee hearing. RFK Jr.’s announcement was in response to a line of questioning by Senator Josh Hawley. Hawley asked the secretary if he was aware of the recently released study by the Ethics and Public Policy Ce…
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. Pledges to do a “Complete Review” of Chemical Abortion Pills After New Data Reveals Safety Risks - Students for Life of America
In an explosive development in the ongoing pushback against Chemical Abortion Pills, the head of the U.S. Health and Human Services (HHS), Robert Kennedy Jr., has ordered the Food & Drug Administration (FDA) to conduct a “complete review” of the pills following new reports on their potential dangers. Commenting on new data about adverse health events from taking Chemical Abortion ...
RFK Orders "Complete Review" Of Abortion Pill
Bloomberg/Bloomberg/Getty ImagesDuring a meeting of the Senate Hearing on the Department of Health and Human Services’ (HHS) fiscal year 2026 budget, Secretary Robert Kennedy stated his intention to oversee a “complete review” of the so-called abortion pill mifepristone after expressing concerns regarding its safety. The secretary’s apprehension regarding mifepristone is based, in part, he says, on the findings of a paper published earlier this …
Coverage Details
Bias Distribution
- 61% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
